Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Filings indexed 1,031 across all filing types
Latest filing 2025-11-20 Major Shareholding Noti…
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
OXUR-Transparency-Notification-NL-20251120.pdf
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding a change in shareholding levels (transparency notification) for Oxurion NV. It explicitly mentions that Atlas Special Opportunities II LLC crossed a threshold (15%) due to the sale of voting securities. This aligns perfectly with the definition of a 'Major Shareholding Notification' (MRQ), which covers notifications of changes in significant share ownership levels.
2025-11-20 English
OXUR-PR_UPDATE-ENG_251103.pdf
M&A Activity Classification · 100% confidence The document is a press release announcing the termination of a previously announced acquisition (preclinical transaction) and providing an update on the status of another ongoing acquisition (clinical partner). Since the document details specific M&A activity, including the cancellation of one deal and the progress of another, it falls under the M&A Activity category.
2025-11-03 English
OXUR-PR_UPDATE-FR_251103.pdf
M&A Activity Classification · 95% confidence The document is a press release from Oxurion NV announcing the termination of a previously announced acquisition (preclinical services) and the continuation of another acquisition (clinical services). This falls under M&A activity, specifically the announcement of changes to merger/acquisition plans. It is not a report publication announcement (RPA) as it provides substantive details on corporate strategy and transaction status rather than just announcing the availability of a report.
2025-11-03 French
OXUR-PR_UPDATE-NED_251103.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from Oxurion NV announcing the termination of discussions regarding a previously announced preclinical acquisition and providing an update on the progress of another clinical integration transaction. This falls under M&A activity (mergers, acquisitions, and takeover bids). It is not a report itself, but an announcement of corporate strategy and transaction status.
2025-11-03 Dutch
OXUR-Transparency-Notification-EN-20251023.pdf
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding a change in major shareholding (crossing the 15% threshold) by Atlas Special Opportunities II LLC in Oxurion NV. It includes a press release and the official FSMA Transparency Notification Form TR-1. This type of filing is specifically categorized as a Major Shareholding Notification.
2025-10-23 English
OXUR-Transparency-Notification-NL-20251023.pdf
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement regarding a 'transparantiekennisgeving' (transparency notification) received by Oxurion NV from Atlas Special Opportunities II LLC. It details that the shareholder has crossed a 15% voting rights threshold. This type of disclosure, concerning changes in significant share ownership, is classified as a Major Shareholding Notification.
2025-10-23 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.